BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12453547)

  • 21. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
    Nodari S; Metra M; Dei Cas L
    Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction.
    Udelson JE; DeAbate CA; Berk M; Neuberg G; Packer M; Vijay NK; Gorwitt J; Smith WB; Kukin ML; LeJemtel T; Levine TB; Konstam MA
    Am Heart J; 2000 Mar; 139(3):503-10. PubMed ID: 10689266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K; Park TH
    Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nebivolol in the treatment of ischemic heart disease patients with chronic heart failure].
    Evdokimova AG; Radzevich AE; Tereshchenko OI; Pichugina TA; Kovalenko EV
    Kardiologiia; 2004; 44(2):15-8. PubMed ID: 15029131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.
    Palazzuoli A; Bruni F; Puccetti L; Pastorelli M; Angori P; Pasqui AL; Auteri A
    Eur J Heart Fail; 2002 Dec; 4(6):765-70. PubMed ID: 12453548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
    Del Sindaco D; Tinti MD; Monzo L; Pulignano G
    Clin Interv Aging; 2010 Dec; 5():381-93. PubMed ID: 21152240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure.
    Karabacak M; Doğan A; Tayyar Ş; Özaydın M; Erdoğan D
    Anatol J Cardiol; 2015 Apr; 15(4):271-6. PubMed ID: 25413223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
    Stoleru L; Wijns W; van Eyll C; Bouvy T; Van Nueten L; Pouleur H
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects.
    Valentini M; Revera M; Bilo G; Caldara G; Savia G; Styczkiewicz K; Parati S; Gregorini F; Faini A; Branzi G; Malfatto G; Magrì D; Agostoni P; Parati G
    Cardiovasc Ther; 2012 Aug; 30(4):240-8. PubMed ID: 21883997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure.
    Brune S; Schmidt T; Tebbe U; Kreuzer H
    Angiology; 1990 Sep; 41(9 Pt 1):696-701. PubMed ID: 1977335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebivolol for the treatment of heart failure.
    Dery AS; Hamilton LA; Starr JA
    Am J Health Syst Pharm; 2011 May; 68(10):879-86. PubMed ID: 21546638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA; Doehner W; van der Horst IC; Anker SD; Babalis D; Roughton M; Coats AJ; Flather MD; van Veldhuisen DJ;
    Am J Cardiol; 2010 Jul; 106(1):78-86.e1. PubMed ID: 20609652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of nebivolol on left ventricular remodeling in patients with arterial hypertension without chronic heart failure].
    Khurs EM; Zinov'eva IuA; Poddubnaia AV; Smolenskaia OG
    Kardiologiia; 2007; 47(12):15-9. PubMed ID: 18260973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.
    Marazzi G; Volterrani M; Caminiti G; Iaia L; Massaro R; Vitale C; Sposato B; Mercuro G; Rosano G
    J Card Fail; 2011 Sep; 17(9):703-9. PubMed ID: 21872138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with essential hypertension and OSA.
    Heitmann J; Greulich T; Reinke C; Koehler U; Vogelmeier C; Becker HF; Schmidt AC; Canisius S
    Curr Med Res Opin; 2010 Aug; 26(8):1925-32. PubMed ID: 20560730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.